A
Agile Therapeutics
Agile Therapeutics (C)2011
About Agile Therapeutics
Agile Therapeutics is a healthcare company focused on developing and commercializing innovative contraceptive products for women. The company operates in the pharmaceutical and biotechnology market, specifically targeting women's health. Agile Therapeutics is committed to providing women with more choices in their healthcare, which is reflected in their product pipeline and their proprietary Skinfusion Technology. This technology is used in all of their current products and product candidates, ensuring effective and reliable delivery of medication through the skin.
The company's flagship product, Twirla, is a contraceptive patch that offers an alternative to traditional birth control methods. Twirla is designed to be easy to use and provides a consistent dose of hormones to prevent pregnancy. Agile Therapeutics serves women who are looking for convenient and effective contraceptive options.
Agile Therapeutics operates on a business model that involves the research, development, and commercialization of pharmaceutical products. They generate revenue primarily through the sale of their approved products, like Twirla. Additionally, they invest in ongoing research and development to expand their product offerings and improve existing ones. The company also collaborates with third parties under confidentiality agreements to enhance their operations and services.
In summary, Agile Therapeutics is dedicated to advancing women's health by offering innovative contraceptive solutions. Their focus on research and development, combined with their proprietary technology, positions them as a key player in the women's healthcare market.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Listing
- IPO 2014
- Outcome tier
- Colt$25–100M revenue
News
Open roles
Agile Therapeutics in the Princeton ecosystem
The Agile Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
The Hillman Companies
Series A2 investors entered at this stage
- CCCare Capital
Investor Growth Capital
Series B and later6 investors entered at this stage
Aisling Capital
Oxford Finance
RA Capital Management- PIProQuest Investments
CAM Capital
Perceptive Advisors
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about Agile Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Agile Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


